ArticleCancer research communications2022

Clinical Pharmacology and Determinants of Response to UCART19, an Allogeneic Anti-CD19 CAR-T Cell Product, in Adult B-cell Acute Lymphoblastic Leukemia.

Sandra Dupouy et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.